Upregulations of glucocorticoid-induced leucine zipper by hypoxia and glucocorticoid inhibit proinflammatory cytokines under hypoxic conditions in macrophages

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 222-229

  Wang, Yan ^a   Ma, Yuan Yuan ^a   Song, Xing Lei ^a   Cai, Hao Yu ^a   Chen, Ji Cheng ^a   Song, Liang Nian ^b   Yang, Rui ^a   Lu, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; UPREGULATION;

ANIMALS; CELL HYPOXIA; CELL LINE; DEXAMETHASONE; GLUCOCORTICOIDS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MONOKINES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84855387231     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002958     Document Type: Article

References (50)

1. Nathan, C. 2003. Immunology: Oxygen and the inflammatory cell. Nature 422: 675-676. (Pubitemid 36514097)
2. Karhausen, J., V. H. Haase, and S. P. Colgan. 2005. Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle 4: 256-258. (Pubitemid 41365330)
3. Basnyat, B., and D. R. Murdoch. 2003. High-altitude illness. Lancet 361: 1967-1974. (Pubitemid 36694589)
4. Murdoch, C., M. Muthana, and C. E. Lewis. 2005. Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175: 6257-6263. (Pubitemid 41598863)
5. Taylor, C. T., and S. P. Colgan. 2007. Hypoxia and gastrointestinal disease. J. Mol. Med. (Berl), 85: 1295-1300. (Pubitemid 50004090)
6. Rosenberger, P., J. M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J. C. Morote-Garcia, K. Unertl, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10: 195-202.
7. Murdoch, C., A. Giannoudis, and C. E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234. (Pubitemid 39331817)
8. Bosco, M. C., M. Puppo, F. Blengio, T. Fraone, P. Cappello, M. Giovarelli, and L. Varesio. 2008. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration. Immunobiology 213: 733-749.
9. Safronova, O., S. Pluemsampant, K. Nakahama, and I. Morita. 2009. Regulation of chemokine gene expression by hypoxia via cooperative activation of NF-kappaB and histone deacetylase. Int. J. Biochem. Cell Biol. 41: 2270-2280.
10. Lewis, C., and C. Murdoch. 2005. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167: 627-635. (Pubitemid 41216349)
11. Hempel, S. L., M. M. Monick, and G. W. Hunninghake. 1996. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14: 170-176. (Pubitemid 126441390)
12. Taylor, C. T. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 586: 4055-4059.
13. Fong, C. C., Q. Zhang, Y. F. Shi, R. S. Wu, W. F. Fong, and M. Yang. 2007. Effect of hypoxia on RAW264.7 macrophages apoptosis and signaling. Toxicology 235: 52-61. (Pubitemid 46669767)
14. Shin, D. H., S. H. Li, S. W. Yang, B. L. Lee, M. K. Lee, and J. W. Park. 2009. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha. FEBS J. 276: 3470-3480.
15. Huang, L. E., and H. F. Bunn. 2003. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278: 19575-19578. (Pubitemid 36799137)
16. Basu, M., R. C. Sawhney, S. Kumar, K. Pal, R. Prasad, and W. Selvamurthy. 2002. Glucocorticoids as prophylaxis against acute mountain sickness. Clin. Endocrinol. (Oxf.) 57: 761-767. (Pubitemid 36963004)
17. Ferrazzini, G., M. Maggiorini, S. Kriemler, P. Bärtsch, and O. Oelz. 1987. Successful treatment of acute mountain sickness with dexamethasone. Br. Med. J. (Clin. Res. Ed.) 294: 1380-1382. (Pubitemid 17078939)
18. Felszeghy, K., G. Banisadr, W. Rostène, C. Nyakas, and F. Haour. 2004. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11: 404-413. (Pubitemid 39370447)
19. Tuor, U. I., C. S. Simone, R. Arellano, K. Tanswell, and M. Post. 1993. Glucocorticoid prevention of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes. Brain Res. 604: 165-172. (Pubitemid 23080110)
20. Baschant, U., and J. Tuckermann. 2010. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120: 69-75.
21. Payne, D. N., and I. M. Adcock. 2001. Molecular mechanisms of corticosteroid actions. Paediatr. Respir. Rev. 2: 145-150. (Pubitemid 32694560)
22. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857. (Pubitemid 26006527)
23. De Bosscher, K., W. Vanden Berghe, and G. Haegeman. 2000. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J. Neuroimmunol. 109: 16-22.
24. Barnes, P. J. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94: 557-572. (Pubitemid 28269054)
25. Göttlicher, M., S. Heck, and P. Herrlich. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. (Berl). 76: 480-489. (Pubitemid 28261257)
26. Kodama, T., N. Shimizu, N. Yoshikawa, Y. Makino, R. Ouchida, K. Okamoto, T. Hisada, H. Nakamura, C. Morimoto, and H. Tanaka. 2003. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J. Biol. Chem. 278: 33384-33391. (Pubitemid 37055791)
27. D'Adamio, F., O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, L. Cannarile, G. Migliorati, and C. Riccardi. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7: 803-812. (Pubitemid 28064893)
28. Cannarile, L., O. Zollo, F. D'Adamio, E. Ayroldi, C. Marchetti, A. Tabilio, S. Bruscoli, and C. Riccardi. 2001. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8: 201-203. (Pubitemid 32201367)
29. Hamdi, H., A. Bigorgne, S. Naveau, A. Balian, L. Bouchet-Delbos, A. M. Cassard-Doulcier, M. C. Maillot, I. Durand-Gasselin, S. Prévot, J. Delaveaucoupet, et al. 2007. Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46: 1986-1992.
30. Ayroldi, E., G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, L. Cannarile, F. D'Adamio, and C. Riccardi. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98: 743-753.
31. Berrebi, D., S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati, L. Bouchet-Delbos, M. C. Maillot, A. Portier, J. Couderc, P. Galanaud, et al. 2003. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an antiinflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101: 729-738. (Pubitemid 36077600)
32. Ayroldi, E., O. Zollo, A. Macchiarulo, B. Di Marco, C. Marchetti, and C. Riccardi. 2002. Glucocorticoid-induced leucine zipper inhibits the Rafextracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell. Biol. 22: 7929-7941. (Pubitemid 35217302)
33. Ayroldi, E., and C. Riccardi. 2009. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23: 3649-3658.
34. Eddleston, J., J. Herschbach, A. L. Wagelie-Steffen, S. C. Christiansen, and B. L. Zuraw. 2007. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 119: 115-122. (Pubitemid 46037795)
35. Brisseau, G. F., S. Grinstein, D. J. Hackam, T. Nordström, M. F. Manolson, A. A. Khine, and O. D. Rotstein. 1996. Interleukin-1 increases vacuolar-type H+-ATPase activity in murine peritoneal macrophages. J. Biol. Chem. 271: 2005-2011. (Pubitemid 26047783)
36. Vivona, M. L., M. Matthay, M. B. Chabaud, G. Friedlander, and C. Clerici. 2001. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am. J. Respir. Cell Mol. Biol. 25: 554-561. (Pubitemid 33087105)
37. Fleshner, M., T. Deak, K. T. Nguyen, L. R. Watkins, and S. F. Maier. 2001. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J. Immunol. 166: 3813-3819. (Pubitemid 32224906)
38. Folkesson, H. G., A. Norlin, Y. Wang, P. Abedinpour, and M. A. Matthay. 2000. Dexamethasone and thyroid hormone pretreatment upregulate alveolar epithelial fluid clearance in adult rats. J. Appl. Physiol. 88: 416-424. (Pubitemid 30097082)
39. Müller, J. M., B. Krauss, C. Kaltschmidt, P. A. Baeuerle, and R. A. Rupec. 1997. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 272: 23435-23439. (Pubitemid 27392486)
40. Minet, E., T. Arnould, G. Michel, I. Roland, D. Mottet, M. Raes, J. Remacle, and C. Michiels. 2000. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468: 53-58. (Pubitemid 30101681)
41. Anand, R. J., S. C. Gribar, J. Li, J. W. Kohler, M. F. Branca, T. Dubowski, C. P. Sodhi, and D. J. Hackam. 2007. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J. Leukoc. Biol. 82: 1257-1265. (Pubitemid 350133524)
42. Park, H. J., H. J. Lee, M. S. Choi, D. J. Son, H. S. Song, M. J. Song, J. M. Lee, S. B. Han, Y. Kim, and J. T. Hong. 2008. JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J. Inflamm. (Lond.) 5: 7.
43. Kim, H. J., K. Tsoyi, J. M. Heo, Y. J. Kang, M. K. Park, Y. S. Lee, J. H. Lee, H. G. Seo, H. S. Yun-Choi, and K. C. Chang. 2007. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid. J. Pharmacol. Exp. Ther. 320: 782-789. (Pubitemid 46147960)
44. Liu, F. Q., Y. Liu, V. C. Lui, J. R. Lamb, P. K. Tam, and Y. Chen. 2008. Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages. Exp. Cell Res. 314: 1327-1336.
45. Brain, J. D. 1992. Mechanisms, measurement, and significance of lung macrophage function. Environ. Health Perspect. 97: 5-10.
46. Yachi, K., K. Inoue, H. Tanaka, H. Yoshikawa, and M. Tohyama. 2007. Localization of glucocorticoid-induced leucine zipper (GILZ) expressing neurons in the central nervous system and its relationship to the stress response. Brain Res. 1159: 141-147. (Pubitemid 47058032)
47. Muller, O. G., R. G. Parnova, G. Centeno, B. C. Rossier, D. Firsov, and J. D. Horisberger. 2003. Mineralocorticoid effects in the kidney: correlation between alphaENaC, GILZ, and Sgk-1 mRNA expression and urinary excretion of Na+ and K+. J. Am. Soc. Nephrol. 14: 1107-1115. (Pubitemid 36514653)
48. Godot, V., G. Garcia, F. Capel, M. Arock, I. Durand-Gasselin, M. L. Asselin-Labat, D. Emilie, and M. Humbert. 2006. Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. Allergy 61: 886-890. (Pubitemid 43893992)
49. Cohen, N., E. Mouly, H. Hamdi, M. C. Maillot, M. Pallardy, V. Godot, F. Capel, A. Balian, S. Naveau, P. Galanaud, et al. 2006. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107: 2037-2044. (Pubitemid 43289388)
50. Leonard, M. O., C. Godson, H. R. Brady, and C. T. Taylor. 2005. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J. Immunol. 174: 2250-2257. (Pubitemid 40223972)